ME charity backs NICE guideline

Medical guidelines on the diagnosis and management of ME and chronic fatigue syndrome (CFS) are being challenged through a judicial review. The case against the National Institute for Health and Clinical Excellence (NICE) is generating considerable interest among the 250,000 people in the UK who have ME, as some patients hope the legal proceedings will lead to the withdrawal of the guideline. However, the charity “Action for ME” said that it supports the NICE guidance.

CEO Sir Peter Spencer said: “Overall we think the NICE guideline represents an opportunity to drive forward the improvement of services for people with M.E. most of whom obtain their treatment from the NHS.
 
“We are concerned by the emphasis on graded exercise therapy (GET) and cognitive behaviour therapy (CBT), as our latest health survey showed 34% of patients who had received GET in the past three years felt worse after treatment. The randomised controlled trials which are cited by NICE are given too much emphasis in view of their limitations.
 
“Nevertheless, we believe that there are other aspects of the NICE guideline which could bring considerable benefits, as long as there is adequate funding for its implementation, especially in terms of training healthcare professionals to understand ME/CFS better.”

He added that more scientific research is needed into the disease mechanisms of ME.
 

Latest Issues

EBME Expo 2026

Coventry Building Society Arena, Coventry
24th – 25th June 2026

AfPP Regional Conferences: Manchester

INNSiDE by Meliá Manchester
20th June 2026

Endoscopic Anterior Skull Base Surgery: Hands-On Cadaveric Course

Division of Anatomy, University of Leeds
29th- 30th June 2026

BLOCKED – Advanced+ | The Wrightington Regional Anaesthesia Interest Group Cadaveric Course

Wrightington Conference Centre
Tuesday 7th – Wednesday 8th July 2026

AESCULAP ACADEMY LIVE - Circular Economy in Action

B. Braun Business Centre, Sheffield
Friday 10th July 2026

AfPP Regional Conferences: Bristol

BAWA Leisure
18th July 2026